Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 上海康德莱企业发展集团股份有限公司，主要从事医用穿刺器械的研发、生产和销售，主要产品为医用穿刺针和医用穿刺器。公司作为全国医用注射器（针）标准化技术委员会委员单位、全国医用输液器具标准化技术委员会委员单位、全国齿科设备标准化技术委员会委员单位，多次承担国家标准和行业标准的制订和修订任务，已牵头或参与制定、修订了2项国家标准和9项行业标准。2013年公司获得上海市企业联合会、上海市企业家协会联合颁发的“2013上海民营企业100强”称号。2013年公司被上海市工商行政管理局评为“上海市著名商标（2013-2015）”。
Main Business 医用穿刺器械的研发、生产和销售。
Legal Representative 张维鑫
Top Executives
董事长：张宪淼
副董事长：项剑勇,陈红琴
董事：张勇,章增华,张维鑫,陈红琴,项剑勇
独立董事：杨峰,郭超,邵军
Top 5 Shareholder
Shareholder name Nature Holding Date
上海康德莱控股集团有限公司流通A股21.20%30/09/2024
上海康德莱控股集团有限公司－上海康德莱控股集团有限公司2021年非公开发行可交换公司债券质押专户流通A股18.59%30/09/2024
长沙械字号医疗投资有限公司流通A股1.31%30/09/2024
上海利捷企业投资有限公司流通A股1.12%30/09/2024
中国工商银行股份有限公司－融通健康产业灵活配置混合型证券投资基金流通A股1.09%30/09/2024
Company Secretary 顾佳俊
Solicitors 北京德恒律师事务所
Auditors 立信会计师事务所（特殊普通合伙）
Tel No 021-69113502
Fax No 021-69113503
Website www.kdlchina.cn
Email kdl@kdlchina.net
Company Address
Register: 上海市嘉定区高潮路658号1幢2楼
Office: 中国上海嘉定区高潮路658号1幢2楼
Listing Date 21/11/2016
Shares Capital
Shares Capital: 441,001,780
Total A Share: 441,001,780
Listed A Share: 441,001,780
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.530
DPS(RMB)* ¥ 0.160
NBV Per Share(RMB)* ¥ 5.455
Market Capitalization(RMB) 3.497B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.